Topical protein based formulation
AssigneeOptimus Salvus Limited
InventorsStella VALENZUELA, Khondker Rufaka HOSSAIN, Joanne PATTERSON
Life of this patent
Estimating the term…
Abstract
The present disclosure generally relates to transdermal formulations comprising one or more chloride intracellular channel (CLIC) proteins in combination with one or more cannabinoid compounds, processes for preparing the transdermal formulations, and applications for the transdermal formulations.
Claims28
A transdermal formulation comprising one or more CLIC proteins and one or more cannabinoid compounds, in a therapeutically and/or prophylactically effective amount, and a carrier.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of reducing and/or preventing oxidative stress in cells of mammalian skin, the method comprising:
- topically administering a transdermal formulation to the mammalian skin, wherein the transdermal formulation comprises a therapeutically and/or prophylactically effective amount of one or more CLIC proteins, one or more cannabinoid compounds, and a carrier.
(canceled)
A method of treating or rejuvenating UV damaged cells and/or preventing UV damage in mammalian skin, the method comprising:
- topically administering a transdermal formulation to the mammalian skin, wherein the transdermal formulation comprises a therapeutically and/or prophylactically effective amount of one or more CLIC proteins, one or more cannabinoid compound compounds, and a carrier.
28-40. (canceled)
Dependencies are inferred from the claim text.